<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Arun Sujenthiran | IKIM MML</title><link>https://mml.kite.ume.de/authors/arun-sujenthiran/</link><atom:link href="https://mml.kite.ume.de/authors/arun-sujenthiran/index.xml" rel="self" type="application/rss+xml"/><description>Arun Sujenthiran</description><generator>HugoBlox Kit (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 01 Feb 2024 00:00:00 +0000</lastBuildDate><item><title>Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting.</title><link>https://mml.kite.ume.de/publications/kersting-characteristics-2024/</link><pubDate>Thu, 01 Feb 2024 00:00:00 +0000</pubDate><guid>https://mml.kite.ume.de/publications/kersting-characteristics-2024/</guid><description/></item></channel></rss>